Acta Chir Orthop Traumatol Cech. 2020; 87(6):429-437 | DOI: 10.55095/achot2020/067
Optimal Route for Tranexamic Acid in Diabetics and Obese Patients Undergoing Primary Total Knee Arthroplasty - a Data from Randomized StudyOriginal papers
- 1 Department of Orthopaedics, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc
- 2 Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacký University Olomouc
PURPOSE OF THE STUDY:
To determine the optimal strategy for tranexamic acid (TXA) administration in diabetic patients, smokers and obese patients (BMI > 30 kg/m2) undergoing primary total knee arthroplasty (TKA).
MATERIAL AND METHODS:
The total of 400 consecutive patients indicated for primary TKA were randomised into 4 basic groups with different TXA administration regimens. Group 1 (IV1) had a single intravenous dose (15 mg TXA/kg) applied prior to skin incision. Group 2 (IV2) got two intravenous doses (15 mg TXA/kg): one prior to skin incision and one subsequently 6 hours after the first dose. Group 3 (TOP) had 2 g TXA in 50 ml of saline irrigated topically at the end of the surgery. Group 4 (COMB) combined IV1 and TOP regimens. We monitored the amount of total blood loss (TBL), haemoglobin drop, use of blood transfusions (BTs), and complications in each patient. Follow-up period was one year postoperatively.
RESULTS:
In the group of diabetic patients (n = 87; 21.7%) the lowest TBL was observed in the order: IV1, IV2 > COMB > TOP. In the obese patients (BMI > 30 kg/m2; n = 242; 60.5%), TBL was significantly lower in the intravenous regimens (IV1: p = 0.002; IV2: p = 0.005, respectively) than in the TOP regimen. In the smoking patients (n = 30; 7.5%), TBLs were significantly lower in the order: IV1 > IV2 > COMB > TOP.
DISCUSSION:
Individualised approach to prevention and therapy is a recent trend, also because comorbidities significantly affect the result of the intervention. In the case of diabetes, obesity and smoking, there is a proven link to early post-operative infections, mainly due to poorer innate immunity. It is conceivable, though, that the occurrence of infectious complications is also contributed to by larger hematomas or hemarthroses which are largely preventable.
CONCLUSIONS:
In the diabetic and obese patients (BMI > 30 kg/m2), the combined topical/intravenous TXA application and two intravenous doses of TXA interventions were shown to be the most effective. However, no evidence of superiority of any of the TXA administration routes was obtained in the smokers. None of the TXA protocols was associated with a higher incidence of complications or early reoperation following TKA surgery.
Keywords: tranexamic acid, topical application, intravenous application, combined administration, diabetes, obesity, BMI, smoking, blood loss, hidden blood loss, total knee arthroplasty, complications
Published: December 1, 2020 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854-865.
- Aguilera X, Martinez-Zapata MJ, Hinarejos P, Jordan M, Leal J, Gonzalez JC, Monllau JC, Celaya F, Rodriguez-Arias A, Fernandez JA, Pelfort X, Puig-Verdie L. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch Orthop Traum Su. 2015;135:1017-1025.
Go to original source...
Go to PubMed...
- Anderson K, Hamm RL. Factors that impair wound healing. J Am Coll Clin Wound Spec. 2012;4:84-91.
Go to original source...
Go to PubMed...
- Duchman KR, Gao Y, Pugely AJ, Martin CT, Noiseux NO, Callaghan JJ. the effect of smoking on short-term complications following total hip and knee arthroplasty. J Bone Joint Surg Am. 2015;97:1049-1058.
Go to original source...
Go to PubMed...
- Electricwala AJ, Jethanandani RG, Narkbunnam R, Huddleston JI, 3rd, Maloney WJ, Goodman SB, Amanatullah DF. Elevated body mass index is associated with early total knee revision for infection. J Arthroplasty. 2017;32:252-255.
Go to original source...
Go to PubMed...
- Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, Bini SA, Clarke HD, Schemitsch E, Johnson RL, Memtsoudis SG, Sayeed SA, Sah AP, Della Valle CJ. The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty. 2018;33:3090-3098.e3091.
Go to original source...
Go to PubMed...
- Gallo J, Radvanský M, Kudělka M, Kriegová E, Loą»ák J. [Smoking, preoperative activity, and waiting time for the surgery could predict the risk of early reoperation in total knee arthroplasty]. Acta Chir Orthop Traumatol Cech. 2018;85:410-417.
Go to original source...
- Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth. 2003;90:596-599.
Go to original source...
Go to PubMed...
- Han YH, Huang HT, Pan JK, Zeng LF, Liang GH, Liang HD, Yang WY, Guo D, Liu J. Is the combined application of both drain-clamping and tranexamic acid superior to the single use of either application in patients with total-knee arthroplasty?: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97:e11573.
Go to original source...
Go to PubMed...
- Jain NP, Nisthane PP, Shah NA. Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplasty. 2016;31:542-547.
Go to original source...
Go to PubMed...
- Kim YT, Kang MW, Lee JK, Lee YM, Kim JI. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis. BMC Musculoskelet Disord. 2018;19:227.
Go to original source...
Go to PubMed...
- Lee SY, Chong S, Balasubramanian D, Na YG, Kim TK. What is the ideal route of administration of tranexamic acid in TKA? A Randomized Controlled Trial. Clin Orthop Relat Res. 2017;475:1987-1996.
Go to original source...
Go to PubMed...
- McPherson EJ, Woodson C, Holtom P, Roidis N, Shufelt C, Patzakis M. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res. 2002;403:8-15.
Go to original source...
- Meftah M, White PB, Siddiqi A, Siddappa VH, Kirschenbaum I. Tranexamic acid reduces transfusion rates in obese patients undergoing total joint arthroplasty. Surg Technol Int. 2019;34:451-455.
Go to PubMed...
- Meng Y, Li Z, Gong K, An X, Dong J, Tang P. Tranexamic acid reduces intraoperative occult blood loss and tourniquet time in obese knee osteoarthritis patients undergoing total knee arthroplasty: a prospective cohort study. Ther Clin Risk Manag. 2018;14:675-683.
Go to original source...
Go to PubMed...
- Oremus K. Tranexamic acid for the reduction of blood loss in total knee arthroplasty. Ann Transl Med. 2015;3(Suppl 1):S40.
Go to PubMed...
- Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag. 2017;20:6-12.
Go to original source...
Go to PubMed...
- Shin YS, Yoon JR, Lee HN, Park SH, Lee DH. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2017;25:3585-3595.
Go to original source...
Go to PubMed...
- Tew M, Dowsey MM, Choong A, Choong PF, Clarke P. Co-morbidities and sex differences in long-term quality-of-life outcomes among patients with and without diabetes after total knee replacement: five-year data from registry study. J Clin Med. 2019;9:19.
Go to original source...
Go to PubMed...
- Xiong H, Liu Y, Zeng Y, Wu Y, Shen B. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2018;19:321.
Go to original source...
Go to PubMed...
- Zhang H, He G, Zhang C, Xu B, Wang X, Zhang C. Is combined topical and intravenous tranexamic acid superior to intravenous tranexamic acid alone for controlling blood loss after total hip arthroplasty?: A meta-analysis. Medicine (Baltimore). 2017;96:e6916.
Go to original source...
Go to PubMed...
- Zhang S, Wang C, Shi L, Xue Q. Multi-route applications of tranexamic acid to reduce blood loss after total knee arthroplasty: a randomized controlled trial. Medicine (Baltimore). 2019;98:e16570.
Go to original source...
Go to PubMed...